Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA contact with Congress

Executive Summary

Should be routed through the HHS assistant secretary for legislation office, HHS Secretary Sullivan said in a recent memo to departmental and agency heads. "I believe that extensive consultation with Congress is imperative," the memo states. "I have vested the assistant secretary for legislation with responsibility for the management of this Department's relationships with Congress." Specifically, meetings, calls and staff contacts with members of Congress or their staffs "should not occur without prior consultation" with the Office of the Assistant Secretary.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS016032

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel